Enterococcus faecium SF68

Enterococcus faecium SF68 is a clinically-studied probiotic strain that produces antimicrobial compounds and bacteriocins to support digestive health. It works by adhering to intestinal epithelial cells and modulating gut microbiota composition while enhancing mucosal barrier function.

Origin & History

Enterococcus faecium SF68 is a probiotic strain originally isolated from the gut of healthy humans. It is commonly used in dietary supplements and animal feeds for its beneficial effects on gastrointestinal health.

Historical & Cultural Context

Enterococcus faecium SF68 has been used in Europe for decades as a probiotic supplement for both humans and animals. Its use is rooted in traditional practices of enhancing gut health through beneficial bacteria.

Health Benefits

- Supports digestive health by maintaining a balanced gut microbiota, which improves nutrient absorption and reduces bloating. - Enhances immune function by stimulating the production of protective antibodies, reducing the risk of infections. - May improve skin health by promoting a balanced gut microbiome, which is linked to reduced acne and eczema flare-ups. - Reduces inflammation by modulating immune responses, which can alleviate symptoms of inflammatory bowel diseases. - Supports cardiovascular health by reducing cholesterol levels, as shown in studies where participants experienced a 10% reduction in LDL cholesterol. - Enhances mental health by producing neurotransmitters like serotonin, which can improve mood and reduce anxiety. - Supports oral health by inhibiting the growth of harmful bacteria in the mouth, reducing the risk of cavities.

How It Works

Enterococcus faecium SF68 produces bacteriocins and organic acids that inhibit pathogenic bacteria while promoting beneficial microbial growth. The strain adheres to intestinal epithelial cells via surface adhesins, enhancing mucosal barrier integrity and stimulating secretory IgA production. It modulates immune responses through interaction with Peyer's patches and dendritic cells in gut-associated lymphoid tissue.

Scientific Research

Enterococcus faecium SF68 has been studied for its role in maintaining gut health and preventing diarrhea, with several clinical trials supporting its efficacy. However, more research is needed to fully understand its mechanisms of action.

Clinical Summary

Clinical studies on E. faecium SF68 include randomized controlled trials with sample sizes ranging from 50-200 participants. Research shows significant reduction in antibiotic-associated diarrhea duration by 1-2 days compared to placebo. Studies demonstrate improved stool consistency and reduced bloating symptoms in 60-70% of participants with digestive issues. Evidence quality is moderate, with most studies conducted over 2-4 week periods in healthy adults and children.

Nutritional Profile

- Contains live probiotic bacteria. - Low in calories and fat. - Free from artificial additives. - Often found in capsule or powder form.

Preparation & Dosage

Typical dosage ranges from 1 to 10 billion CFU per day. Consult a healthcare provider before use.

Synergy & Pairings

Lactobacillus acidophilus, Bifidobacterium lactis, Saccharomyces boulardii

Safety & Interactions

Enterococcus faecium SF68 is generally well-tolerated with mild side effects including temporary gas or bloating in sensitive individuals. No significant drug interactions have been reported, though it should be taken 2 hours apart from antibiotics to maintain viability. Immunocompromised individuals should consult healthcare providers before use due to potential risk of opportunistic infections. Safety during pregnancy and breastfeeding has not been established through controlled studies.